Weekly Topotecan Therapy in Patients With Ovarian Cancer

NCT00194935 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Topotecan

Sponsor

Weill Medical College of Cornell University